Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3-year follow-up of alisporivir non-SVR patients for HCV resistance
2011-006132-24Phase 3Terminated
- Sponsor
- Novartis
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of alisporivir in hepatitis C virus infection, sponsored by Novartis. Primary endpoint: Time to reversion to wild-type. Started Apr 2012; status: terminated.
02
Drugs
alisporivir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2011-006132-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006132-24.